174 related articles for article (PubMed ID: 33790491)
41. Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia.
See JA; Shumack S; Murrell DF; Rubel DM; Fernández-Peñas P; Salmon R; Hewitt D; Foley P; Spelman L
Australas J Dermatol; 2016 Aug; 57(3):167-74. PubMed ID: 26033230
[TBL] [Abstract][Full Text] [Related]
42. MAL Daylight Photodynamic Therapy for Actinic Keratosis: Clinical and Imaging Evaluation by 3D Camera.
Cantisani C; Paolino G; Pellacani G; Didona D; Scarno M; Faina V; Gobello T; Calvieri S
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27409613
[TBL] [Abstract][Full Text] [Related]
43. Treatment of Actinic Keratoses: A Randomized Split-Site Approach Comparison of Sequential 5-Fluorouracil and 5-Aminolevulinic Acid Photodynamic Therapy to 5-Aminolevulinic Acid Photodynamic Monotherapy.
Pei S; Kaminska ECN; Tsoukas MM
Dermatol Surg; 2017 Sep; 43(9):1170-1175. PubMed ID: 28562434
[TBL] [Abstract][Full Text] [Related]
44. Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses.
Fauteck JD; Ackermann G; Birkel M; Breuer M; Moor AC; Ebeling A; Ortland C
Arch Dermatol Res; 2008 Feb; 300(2):53-60. PubMed ID: 17960406
[TBL] [Abstract][Full Text] [Related]
45. Daylight Photodynamic Therapy for Actinic Keratoses.
Morton CA; Braathen LR
Am J Clin Dermatol; 2018 Oct; 19(5):647-656. PubMed ID: 29752702
[TBL] [Abstract][Full Text] [Related]
46. Daylight photodynamic therapy is an option for the treatment of actinic keratosis in patients with xeroderma pigmentosum in Africa.
Fernández-Guarino M; Mavura D; Fernández-González P; Chapa P; Ravazzano C; Jaén L; Rios L; Jaén P; Grossman H
Photodiagnosis Photodyn Ther; 2020 Mar; 29():101631. PubMed ID: 31904551
[TBL] [Abstract][Full Text] [Related]
47. Increased protoporphyrin IX accumulation does not improve the effect of photodynamic therapy for actinic keratosis: a randomized controlled trial.
Nissen CV; Heerfordt IM; Wiegell SR; Mikkelsen CS; Wulf HC
Br J Dermatol; 2017 May; 176(5):1241-1246. PubMed ID: 27696393
[TBL] [Abstract][Full Text] [Related]
48. Metronomic Photodynamic Therapy with Conjugated Polymer Nanoparticles in Glioblastoma Tumor Microenvironment.
Caverzán MD; Oliveda PM; Beaugé L; Palacios RE; Chesta CA; Ibarra LE
Cells; 2023 Jun; 12(11):. PubMed ID: 37296661
[TBL] [Abstract][Full Text] [Related]
49. Photodynamic therapy using direct-current pulsed iontophoresis for 5-aminolevulinic acid application.
Mizutani K; Watanabe D; Akita Y; Akimoto M; Tamada Y; Matsumoto Y
Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):280-2. PubMed ID: 19747250
[TBL] [Abstract][Full Text] [Related]
50. Bucher's indirect comparison of daylight photodynamic therapy with methyl aminolevulinate cream versus diclofenac plus hyaluronic acid gel for the treatment of multiple actinic keratosis.
Calzavara-Pinton P; Zane C; Pacou M; Szeimies RM
Eur J Dermatol; 2016 Oct; 26(5):487-492. PubMed ID: 27352420
[TBL] [Abstract][Full Text] [Related]
51. A New Light-Emitting, Fabric-Based Device for Photodynamic Therapy of Actinic Keratosis: Protocol for a Randomized, Controlled, Multicenter, Intra-Individual, Phase II Noninferiority Study (the Phosistos Study).
Vignion-Dewalle AS; Abi Rached H; Thecua E; Lecomte F; Deleporte P; Béhal H; Hommel T; Duhamel A; Szeimies RM; Mortier L; Mordon S
JMIR Res Protoc; 2019 Apr; 8(4):e12990. PubMed ID: 31025953
[TBL] [Abstract][Full Text] [Related]
52. Update on photodynamic treatment for actinic keratosis.
Wiegell SR
Curr Probl Dermatol; 2015; 46():122-8. PubMed ID: 25561216
[TBL] [Abstract][Full Text] [Related]
53. A suppository kit for metronomic photodynamic therapy: The elimination of rectal cancer in situ.
Shi XF; Jin WD; Gao H; Yin HJ; Li YX; Huang H; Ma H; Dong HJ
J Photochem Photobiol B; 2018 Apr; 181():143-149. PubMed ID: 29567315
[TBL] [Abstract][Full Text] [Related]
54. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.
Reinhold U; Dirschka T; Ostendorf R; Aschoff R; Berking C; Philipp-Dormston WG; Hahn S; Lau K; Jäger A; Schmitz B; Lübbert H; Szeimies RM
Br J Dermatol; 2016 Oct; 175(4):696-705. PubMed ID: 26921093
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of different photoprotection strategies in preventing actinic keratosis new lesions after photodynamic therapy. The ATHENA study: a two-center, randomized, prospective, assessor-blinded pragmatic trial.
Pavone PS; Lovati S; Scarcella G; Milani M
Curr Med Res Opin; 2019 Jan; 35(1):141-145. PubMed ID: 30404544
[No Abstract] [Full Text] [Related]
56. Evaluating the Noninferiority of a New Photodynamic Therapy (Flexitheralight) Compared With Conventional Treatment for Actinic Keratosis: Protocol for a Phase 2 Study.
Lecomte F; Vignion-Dewalle AS; Vicentini C; Thecua E; Deleporte P; Duhamel A; Mordon S; Mortier L
JMIR Res Protoc; 2019 Apr; 8(4):e11530. PubMed ID: 31025952
[TBL] [Abstract][Full Text] [Related]
57. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
[TBL] [Abstract][Full Text] [Related]
58. Safety and Efficacy of Aminolevulinic Acid 10% Topical Gel versus Aminolevulinic Acid 20% Topical Solution Followed by Blue-light Photodynamic Therapy for the Treatment of Actinic Keratosis on the Face and Scalp: A Randomized, Double-blind Study.
Nestor MS; Berman B; Patel J; Lawson A
J Clin Aesthet Dermatol; 2019 Mar; 12(3):32-38. PubMed ID: 30988871
[No Abstract] [Full Text] [Related]
59. Deep proteome profiling of SW837 cells treated by photodynamic therapy (PDT) reveals the underlying mechanisms of metronomic and acute PDTs.
Gao H; Shi X; Chen Q; Che B; Yin H; Li Y
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101809. PubMed ID: 32437970
[TBL] [Abstract][Full Text] [Related]
60. Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: Evidence from a clinical and meteorological study.
Spelman L; Rubel D; Murrell DF; See JA; Hewitt D; Foley P; Salmon R; Kerob D; Pascual T; Shumack S; Fernandez-Penas P
Australas J Dermatol; 2016 Feb; 57(1):24-8. PubMed ID: 25827200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
